Mtem

Developer of next-gen immunotoxins for cancer

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2004 groups222 employees language mtem.com

Registered entities

Investor mix

15 investors on record.

Investor typeCountShare
Venture capital640%
Private equity640%
Bank & private debt17%
Other / undisclosed213%
Coming soon